Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer.

Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, Wang Q, Neff RA, Golomb SM, Lewis C, Peng Y, Howe EN, Zhang S
Nat Commun. 2023 Apr 13;14(1):2109. doi: 10.1038/s41467-023-37727-y. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.